Adult cancer pain: Clinical Practice Guidelines in Oncology™

JNCCN Journal of the National Comprehensive Cancer Network

Volumn 5, Issue 8, 2007, Pages 726-751

  Swarm, Robert ^a   Anghelescu, Doralina L ^b   Benedetti, Costantino ^c   Boston, Barry ^b   Cleeland, Charles ^d   Coyle, Nessa ^e   DeLeon Casasola, Oscar A ^f   Eidelman, Anthony ^a   Eilers, June G ^g   Ferrell, Betty ^h   Grossman, Stuart A ⁱ   Janjan, Nora A ^d   Levy, Michael H ^j   Lynch, Maureen ^k   Montana, Gustavo S ^l   Nesbit, Suzanne ⁱ   Oakes, Linda ^b   Obbens, Eugenie A ^e   Paice, Judy ^l   Syrjala, Karen L ^m   Urba, Susan ⁿ   Weinstein, Sharon M ^o   more..

^a BARNES JEWISH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE CANCER INSTITUTE   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^f ROSWELL PARK CANCER INSTITUTE   (United States)

^g NEBRASKA MEDICAL CENTER   (United States)

^h Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins ^*

ⁱ JOHNS HOPKINS UNIVERSITY   (United States)

^j MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

^k DUKE CANCER INSTITUTE   (United States)

^l NORTHWESTERN UNIVERSITY   (United States)

^m UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

ⁿ UNIVERSITY OF UTAH   (United States)

^o WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

Cancer; Malignancy; NCCN Clinical Practice Guidelines; Pain; Pain assessment; Pain intensity rating

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CAPSAICIN; CARBAMAZEPINE; CODEINE; CYCLOOXYGENASE 2 INHIBITOR; DESIPRAMINE; DOXEPIN; DULOXETINE; FENTANYL; GABAPENTIN; HYDROCODONE; HYDROMORPHONE; IBUPROFEN; LAXATIVE; LEVORPHANOL; LIDOCAINE; METHADONE; MORPHINE; MORPHINE SULFATE; NONSTEROID ANTIINFLAMMATORY AGENT; NORTRIPTYLINE; OPIATE; OXYCODONE; PARACETAMOL; PREGABALIN; SALSALATE; VENLAFAXINE;

BONE PAIN; CANCER PAIN; CONFERENCE PAPER; CONSTIPATION; DELIRIUM; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; FAMILY ATTITUDE; FOLLOW UP; GASTROINTESTINAL TOXICITY; HEALTH SERVICE; HUMAN; NAUSEA; NEPHROTOXICITY; NERVE BLOCK; NERVE STIMULATION; NEUROPATHIC PAIN; NOCICEPTION; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PAIN PARAMETERS; PATHOPHYSIOLOGY; PATIENT EDUCATION; PRACTICE GUIDELINE; PSYCHOSOCIAL CARE; QUALITY OF LIFE; RESPIRATION DEPRESSION; RISK FACTOR; SEDATION; SIDE EFFECT; TREATMENT DURATION; TREATMENT INDICATION;

ANALGESICS; DECISION TREES; DRUG ADMINISTRATION SCHEDULE; HUMANS; NEOPLASMS; PAIN MEASUREMENT; PAIN, INTRACTABLE;

EID: 34848841547     PISSN: 15401405     EISSN: 15401413     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (21)

1. Classification of chronic pain. Descriptions of chronic pain syndromes and definitions of pain terms. Prepared by the International Association for the Study of Pain, Subcommittee on Taxonomy. Pain Suppl 1986;3:S1-226.
2. Cohen MZ, Easley MK, Ellis C, et al. Cancer pain management and the JCAHO's pain standards: an institutional challenge. J Pain Symptom Manage 2003;25:519-527.
3. Goudas LC, Bloch R, Gialeli-Goudas M, et al. The epidemiology of cancer pain. Cancer Invest 2005;23:182-190.
4. Svendsen KB, Andersen S, Arnason S, et al. Breakthrough pain in malignant and non-malignant diseases: a review of prevalence, characteristics and mechanisms. Eur J Pain 2005;9:195-206.
5. Cleeland CS, Gonin R, Hatfield AK, et al. Pain and its treatment in outpatients with metastatic cancer. N Engl J Med 1994;330:592-596.
6. Martin LA, Hagen NA. Neuropathic pain in cancer patients: mechanisms, syndromes, and clinical controversies. J Pain Symptom Manage 1997;14:99-117.
7. Mercadante S. Malignant bone pain: pathophysiology and treatment. Pain 1997;69:1-18.
8. Stjernsward J. WHO cancer pain relief programme. Cancer Surv 1988;7:195-208.
9. Stjernsward J, Colleau SM, Ventafridda V. The World Health Organization cancer pain and palliative care program. Past, present, and future. J Pain Symptom Manage 1996;12:65-72.
10. Hewitt DJ. The management of pain in the oncology patient. Obstet Gynecol Clin North Am 2001;28:819-846.
11. Caraceni A, Weinstein SM. Classification of cancer pain syndromes. Oncology (Williston Park) 2001;15:1627-1640.
12. Serlin RC, Mendoza TR, Nakamura Y, et al. When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain 1995;61:277-284.
13. Soetenga D, Frank J, Pellino TA. Assessment of the validity and reliability of the University of Wisconsin Children's Hospital pain scale for preverbal and nonverbal children. Pediatr Nuts 1999; 25:670-676.
14. Stockler M, Vardy J, Pillai A, Warr D. Acetaminophen (paracetamol) improves pain and well-being in people with advanced cancer already receiving a strong opioid regimen: a randomized, double-blind, placebo-controlled cross-ovet trial. J Clin Oncol 2004;22: 3389-3394.
15. McNicol E, Horowicz-Mehler N, Fisk RA, et al. Management of opioid side effects in cancer-related and chronic noncancer pain: a systematic review. J Pain 2003;4:231-256.
16. Bruera E, Kim HN. Cancer pain. JAMA 2003;290:2476-2479.
17. Cherny NI. The pharmacologic management of cancer pain. Oncology (Williston Park) 2004;18:1499-1515.
18. Stevens RA, Ghazi SM. Routes of opioid analgesic therapy in the management of cancer pain. Cancer Control 2000;7:132-141.
19. Portenoy RK, Lesage P. Management of cancer pain. Lancet 1999; 353:1695-1700.
20. Panchal SJ. Intrathecal pumps. Techniques in regional anesthesia and pain management 2000;4:137-142.
21. Chen H, Lamer TJ, Rho RH, et al. Contemporary management of neuropathic pain for the primary care physician. Mayo Clin Proc 2004; 79:1533-1545.